Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lu AE58054 adjunctive therapy to acetylcholinesterase inhibitors in mild-moderate Alzheimer's disease
2012-004765-40Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Idalopirdine in Alzheimer's disease (AD), sponsored by Lundbeck. Started Dec 2013; status: completed.
02
Drugs
Idalopirdine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2012-004765-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004765-40.